CBUS

SEC source: 0000899243-23-015395 · doc4a.xml · nonDerivative · entry 1

Finn Mark Terrence · CIK 0001976904 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,222,566

F1 · price: Represents shares of Class A Common Stock received as consideration in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated January 13, 2023, as amended by the First Amendment to the Merger Agreement, dated April 14, 2023 (as amended, the "Merger Agreement"), by and among Cibus, Inc. (formerly Calyxt, Inc.) (the "Issuer", and prior to the closing of the transactions contemplated by the Merger Agreement, "Calyxt"), Calypso Merger Subsidiary, LLC, Cibus Global, LLC ("Cibus Global") and certain blocker entities party thereto.

F2 · price: Gives effect to the 1-for-5 reverse stock split of Calyxt's common stock on May 31, 2023. On the closing date, the closing price of Calyxt's common stock was $6.30. Upon closing, Calyxt was renamed "Cibus, Inc.", the Issuer's Amended and Restated Certificate of Incorporation was amended such that the Issuer had two classes of common stock (Class A Common Stock and Class B Common Stock), and Calyxt's existing common stock remained as Class A Common Stock.

F3 · ownership.nature: Held of record by Delta III Partners, LLC, for which the reporting person serves as a managing member and shares voting and dispositive power.

SEC source: 0000899243-23-015559 · doc4.xml · derivative · entry 8

Finn Jonathan · CIK 0001981595 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,518,015

Underlying: Class A Common Stock · 12,048 shares

Expires not disclosed

F7 · derivative.exercise_price: The Cibus Global Common Units, together with the Class B Common Stock (collectively, "Up-C Units") are generally exchangeable by the reporting person for shares of Class A Common Stock on a one-for-one basis, or, subject to certain restrictions, the cash equivalent with respect to all or a portion thereof, based on a volume-weighted average price of a share of Class A Common Stock pursuant to the terms of the Exchange Agreement, dated May 31, 2023, by and among the Issuer, Cibus Global, and the Up-C Unit holders.

F8 · price: Represents Cibus Global Common Units received as consideration in connection with the Merger Agreement.

F7 · derivative.exercise_date: The Cibus Global Common Units, together with the Class B Common Stock (collectively, "Up-C Units") are generally exchangeable by the reporting person for shares of Class A Common Stock on a one-for-one basis, or, subject to certain restrictions, the cash equivalent with respect to all or a portion thereof, based on a volume-weighted average price of a share of Class A Common Stock pursuant to the terms of the Exchange Agreement, dated May 31, 2023, by and among the Issuer, Cibus Global, and the Up-C Unit holders.

F7 · derivative.expiration_date: The Cibus Global Common Units, together with the Class B Common Stock (collectively, "Up-C Units") are generally exchangeable by the reporting person for shares of Class A Common Stock on a one-for-one basis, or, subject to certain restrictions, the cash equivalent with respect to all or a portion thereof, based on a volume-weighted average price of a share of Class A Common Stock pursuant to the terms of the Exchange Agreement, dated May 31, 2023, by and among the Issuer, Cibus Global, and the Up-C Unit holders.

F5 · ownership.nature: Held of record by Delta III Partners, LLC, for which the reporting person serves as a managing member and shares voting and dispositive power.

SEC source: 0000899243-23-015559 · doc4.xml · derivative · entry 7

Finn Jonathan · CIK 0001981595 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,505,967

Underlying: Class A Common Stock · 1,505,967 shares

Expires not disclosed

F7 · derivative.exercise_price: The Cibus Global Common Units, together with the Class B Common Stock (collectively, "Up-C Units") are generally exchangeable by the reporting person for shares of Class A Common Stock on a one-for-one basis, or, subject to certain restrictions, the cash equivalent with respect to all or a portion thereof, based on a volume-weighted average price of a share of Class A Common Stock pursuant to the terms of the Exchange Agreement, dated May 31, 2023, by and among the Issuer, Cibus Global, and the Up-C Unit holders.

F8 · price: Represents Cibus Global Common Units received as consideration in connection with the Merger Agreement.

F7 · derivative.exercise_date: The Cibus Global Common Units, together with the Class B Common Stock (collectively, "Up-C Units") are generally exchangeable by the reporting person for shares of Class A Common Stock on a one-for-one basis, or, subject to certain restrictions, the cash equivalent with respect to all or a portion thereof, based on a volume-weighted average price of a share of Class A Common Stock pursuant to the terms of the Exchange Agreement, dated May 31, 2023, by and among the Issuer, Cibus Global, and the Up-C Unit holders.

F7 · derivative.expiration_date: The Cibus Global Common Units, together with the Class B Common Stock (collectively, "Up-C Units") are generally exchangeable by the reporting person for shares of Class A Common Stock on a one-for-one basis, or, subject to certain restrictions, the cash equivalent with respect to all or a portion thereof, based on a volume-weighted average price of a share of Class A Common Stock pursuant to the terms of the Exchange Agreement, dated May 31, 2023, by and among the Issuer, Cibus Global, and the Up-C Unit holders.

F4 · ownership.nature: Held of record by New Ventures Agtech Solutions, LLC, whose Managing Member is New Ventures Agtech Solutions Manager, LLC. The sole member of New Ventures Agtech Solutions Manager, LLC is Vantage Consulting Group, Inc., for which the reporting person serves as Executive Vice President. The reporting person is a managing member of New Ventures Agtech Solutions Manager, LLC and shares voting and dispositive power.

SEC source: 0000899243-23-015559 · doc4.xml · nonDerivative · entry 6

Finn Jonathan · CIK 0001981595 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,518,015

F6 · price: Represents shares of Class B Common Stock received as consideration in connection with the Merger Agreement, with the number of such shares of Class B Common Stock equal to the number of newly issued membership units of Cibus Global ("Cibus Global Common Units"), received by the reporting person as consideration in connection with the closing of the transactions contemplated by the Merger Agreement. Shares of Class B Common Stock have full voting, but no economic rights. The Issuer is the managing member of Cibus Global, with the Issuer's only material asset consisting of Cibus Global Common Units.

F5 · ownership.nature: Held of record by Delta III Partners, LLC, for which the reporting person serves as a managing member and shares voting and dispositive power.

SEC source: 0000899243-23-015559 · doc4.xml · nonDerivative · entry 5

Finn Jonathan · CIK 0001981595 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,505,967

F6 · price: Represents shares of Class B Common Stock received as consideration in connection with the Merger Agreement, with the number of such shares of Class B Common Stock equal to the number of newly issued membership units of Cibus Global ("Cibus Global Common Units"), received by the reporting person as consideration in connection with the closing of the transactions contemplated by the Merger Agreement. Shares of Class B Common Stock have full voting, but no economic rights. The Issuer is the managing member of Cibus Global, with the Issuer's only material asset consisting of Cibus Global Common Units.

F4 · ownership.nature: Held of record by New Ventures Agtech Solutions, LLC, whose Managing Member is New Ventures Agtech Solutions Manager, LLC. The sole member of New Ventures Agtech Solutions Manager, LLC is Vantage Consulting Group, Inc., for which the reporting person serves as Executive Vice President. The reporting person is a managing member of New Ventures Agtech Solutions Manager, LLC and shares voting and dispositive power.

SEC source: 0000899243-23-015559 · doc4.xml · nonDerivative · entry 4

Finn Jonathan · CIK 0001981595 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,277,453

F1 · price: Represents shares of Class A Common Stock received as consideration in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated January 13, 2023, as amended by the First Amendment to the Merger Agreement, dated April 14, 2023 (as amended, the "Merger Agreement"), by and among Cibus, Inc. (formerly Calyxt, Inc.) (the "Issuer", and prior to the closing of the transactions contemplated by the Merger Agreement, "Calyxt"), Calypso Merger Subsidiary, LLC, Cibus Global, LLC ("Cibus Global") and certain blocker entities party thereto.

F2 · price: Gives effect to the 1-for-5 reverse stock split of Calyxt's common stock on May 31, 2023. On the closing date, the closing price of Calyxt's common stock was $6.30. Upon closing, Calyxt was renamed "Cibus, Inc.", the Issuer's Amended and Restated Certificate of Incorporation was amended such that the Issuer had two classes of common stock (Class A Common Stock and Class B Common Stock), and Calyxt's existing common stock remained as Class A Common Stock.

F5 · ownership.nature: Held of record by Delta III Partners, LLC, for which the reporting person serves as a managing member and shares voting and dispositive power.

SEC source: 0000899243-23-015559 · doc4.xml · nonDerivative · entry 3

Finn Jonathan · CIK 0001981595 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,264,048

F1 · price: Represents shares of Class A Common Stock received as consideration in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated January 13, 2023, as amended by the First Amendment to the Merger Agreement, dated April 14, 2023 (as amended, the "Merger Agreement"), by and among Cibus, Inc. (formerly Calyxt, Inc.) (the "Issuer", and prior to the closing of the transactions contemplated by the Merger Agreement, "Calyxt"), Calypso Merger Subsidiary, LLC, Cibus Global, LLC ("Cibus Global") and certain blocker entities party thereto.

F2 · price: Gives effect to the 1-for-5 reverse stock split of Calyxt's common stock on May 31, 2023. On the closing date, the closing price of Calyxt's common stock was $6.30. Upon closing, Calyxt was renamed "Cibus, Inc.", the Issuer's Amended and Restated Certificate of Incorporation was amended such that the Issuer had two classes of common stock (Class A Common Stock and Class B Common Stock), and Calyxt's existing common stock remained as Class A Common Stock.

F4 · ownership.nature: Held of record by New Ventures Agtech Solutions, LLC, whose Managing Member is New Ventures Agtech Solutions Manager, LLC. The sole member of New Ventures Agtech Solutions Manager, LLC is Vantage Consulting Group, Inc., for which the reporting person serves as Executive Vice President. The reporting person is a managing member of New Ventures Agtech Solutions Manager, LLC and shares voting and dispositive power.

SEC source: 0000899243-23-015559 · doc4.xml · nonDerivative · entry 2

Finn Jonathan · CIK 0001981595 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,145,155

F1 · price: Represents shares of Class A Common Stock received as consideration in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated January 13, 2023, as amended by the First Amendment to the Merger Agreement, dated April 14, 2023 (as amended, the "Merger Agreement"), by and among Cibus, Inc. (formerly Calyxt, Inc.) (the "Issuer", and prior to the closing of the transactions contemplated by the Merger Agreement, "Calyxt"), Calypso Merger Subsidiary, LLC, Cibus Global, LLC ("Cibus Global") and certain blocker entities party thereto.

F2 · price: Gives effect to the 1-for-5 reverse stock split of Calyxt's common stock on May 31, 2023. On the closing date, the closing price of Calyxt's common stock was $6.30. Upon closing, Calyxt was renamed "Cibus, Inc.", the Issuer's Amended and Restated Certificate of Incorporation was amended such that the Issuer had two classes of common stock (Class A Common Stock and Class B Common Stock), and Calyxt's existing common stock remained as Class A Common Stock.

F3 · ownership.nature: Held of record by New Ventures I Holdings, LLC, established by private funds managed by BV Partners, LLC, for which the reporting person serves as one of two managing members. The reporting person holds direct voting and dispositive power over the shares held by the funds managed by BV Partners, LLC. The reporting person disclaims beneficial ownership of the shares held by such private funds except to the extent of his pecuniary interest therein.

SEC source: 0000899243-23-015559 · doc4.xml · nonDerivative · entry 1

Finn Jonathan · CIK 0001981595 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,206

F1 · price: Represents shares of Class A Common Stock received as consideration in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated January 13, 2023, as amended by the First Amendment to the Merger Agreement, dated April 14, 2023 (as amended, the "Merger Agreement"), by and among Cibus, Inc. (formerly Calyxt, Inc.) (the "Issuer", and prior to the closing of the transactions contemplated by the Merger Agreement, "Calyxt"), Calypso Merger Subsidiary, LLC, Cibus Global, LLC ("Cibus Global") and certain blocker entities party thereto.

F2 · price: Gives effect to the 1-for-5 reverse stock split of Calyxt's common stock on May 31, 2023. On the closing date, the closing price of Calyxt's common stock was $6.30. Upon closing, Calyxt was renamed "Cibus, Inc.", the Issuer's Amended and Restated Certificate of Incorporation was amended such that the Issuer had two classes of common stock (Class A Common Stock and Class B Common Stock), and Calyxt's existing common stock remained as Class A Common Stock.

SEC source: 0001615594-23-000025 · primary_doc.xml · nonDerivative · entry 1

Koschak William · CIK 0001763989 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 658,645

F1 · kind: Shares were transferred to reporting person's ex-spouse pursuant to a divorce decree. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse.

SEC source: 0001615594-23-000021 · primary_doc.xml · nonDerivative · entry 1

Carr Michael A. · CIK 0001875512 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 882,011

F1 · shares: Shares were sold to cover withholding obligations of reporting person in connection with the vesting of Restricted Stock Units.

F2 · price: The price reported in column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $0.3326 to $0.355, inclusive.

SEC source: 0001615594-23-000024 · primary_doc.xml · nonDerivative · entry 1

Koschak William · CIK 0001763989 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 669,590

F1 · shares: Shares were sold to cover withholding obligations of reporting person in connection with the vesting of Restricted Stock Units.

F2 · price: The price reported in column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $0.3363 to $0.355, inclusive.

SEC source: 0001615594-23-000023 · primary_doc.xml · nonDerivative · entry 1

Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 661,902

F1 · shares: Shares were sold to cover withholding obligations of reporting person in connection with the vesting of Restricted Stock Units.

F2 · price: The price reported in column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $0.3327 to $0.3602, inclusive.

SEC source: 0001615594-23-000022 · primary_doc.xml · nonDerivative · entry 1

Frey Travis · CIK 0001777352 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 666,327

F1 · shares: Shares were sold to cover withholding obligations of reporting person in connection with the vesting of Restricted Stock Units.

F2 · price: The price reported in column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $0.3325 to $0.355, inclusive.

SEC source: 0001615594-23-000018 · primary_doc.xml · nonDerivative · entry 1

Koschak William · CIK 0001763989 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 681,557

F1 · shares: Shares were sold to cover withholding obligations of reporting person in connection with the vesting of Restricted Stock Units.

F2 · price: The price reported in column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $0.3045 to $0.33, inclusive.

SEC source: 0001615594-23-000019 · primary_doc.xml · nonDerivative · entry 1

Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 673,869

F1 · shares: Shares were sold to cover withholding obligations of reporting person in connection with the vesting of Restricted Stock Units.

F2 · price: The price reported in column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $0.3045 to $0.3318,inclusive.

SEC source: 0001615594-23-000017 · primary_doc.xml · nonDerivative · entry 1

Frey Travis · CIK 0001777352 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 678,294

F1 · shares: Shares were sold to cover withholding obligations of reporting person in connection with the vesting of Restricted Stock Units.

F2 · price: The price reported in column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $0.3045 to $0.3318, inclusive.

SEC source: 0001615594-23-000016 · primary_doc.xml · nonDerivative · entry 1

Carr Michael A. · CIK 0001875512 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 898,036

F1 · shares: Shares were sold to cover withholding tax obligations of reporting person in connection with the vesting of Performance Stock Units.

SEC source: 0001615594-23-000013 · primary_doc.xml · nonDerivative · entry 1

Koschak William · CIK 0001763989 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 684,040

F1 · shares: Shares were sold to cover tax withholding obligations of reporting person in connection with the vesting of Performance Stock Units.

SEC source: 0001615594-23-000014 · primary_doc.xml · nonDerivative · entry 1

Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 676,490

F1 · shares: Shares were sold to cover withholding tax obligations of reporting person in connection with the vesting of Performance Stock Units.

SEC source: 0001615594-23-000015 · primary_doc.xml · nonDerivative · entry 1

Frey Travis · CIK 0001777352 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 680,570

F1 · shares: Shares were sold to cover withholding tax obligations of reporting person in connection with the vesting of Performance Stock Units.

SEC source: 0001615594-23-000008 · primary_doc.xml · nonDerivative · entry 2

Carr Michael A. · CIK 0001875512 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 918,297

F2 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units.

SEC source: 0001615594-23-000008 · primary_doc.xml · nonDerivative · entry 1

Carr Michael A. · CIK 0001875512 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 849,964

F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant.

SEC source: 0001615594-23-000011 · primary_doc.xml · nonDerivative · entry 2

Koschak William · CIK 0001763989 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 696,007

F2 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units.

SEC source: 0001615594-23-000011 · primary_doc.xml · nonDerivative · entry 1

Koschak William · CIK 0001763989 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 662,674

F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant.

SEC source: 0001615594-23-000010 · primary_doc.xml · nonDerivative · entry 2

Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 688,457

F2 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units.

SEC source: 0001615594-23-000010 · primary_doc.xml · nonDerivative · entry 1

Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 655,124

F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant.

SEC source: 0001615594-23-000009 · primary_doc.xml · nonDerivative · entry 2

Frey Travis · CIK 0001777352 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 692,537

F2 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units.

SEC source: 0001615594-23-000009 · primary_doc.xml · nonDerivative · entry 1

Frey Travis · CIK 0001777352 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 659,204

F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant.

SEC source: 0001615594-23-000038 · primary_doc.xml · derivative · entry 6

Nelson Kimberly K. · CIK 0001489097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,100

Underlying: Common Stock · 37,100 shares

Expires 2032-06-13

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000038 · primary_doc.xml · derivative · entry 5

Nelson Kimberly K. · CIK 0001489097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,100 shares

Expires 2032-06-13

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000038 · primary_doc.xml · derivative · entry 4

Nelson Kimberly K. · CIK 0001489097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,231

Underlying: Common Stock · 15,231 shares

Expires 2031-05-27

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000038 · primary_doc.xml · derivative · entry 3

Nelson Kimberly K. · CIK 0001489097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,231 shares

Expires 2031-05-27

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000038 · primary_doc.xml · derivative · entry 2

Nelson Kimberly K. · CIK 0001489097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-08-04

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000038 · primary_doc.xml · derivative · entry 1

Nelson Kimberly K. · CIK 0001489097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2030-08-04

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000037 · primary_doc.xml · derivative · entry 6

Ribeill Yves J · CIK 0001604049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,200

Underlying: Common Stock · 47,200 shares

Expires 2032-06-13

F1 · kind: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

F1 · price: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000037 · primary_doc.xml · derivative · entry 5

Ribeill Yves J · CIK 0001604049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 47,200 shares

Expires 2032-06-13

F1 · kind: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

F1 · price: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000037 · primary_doc.xml · derivative · entry 4

Ribeill Yves J · CIK 0001604049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,291

Underlying: Common Stock · 10,291 shares

Expires 2031-05-27

F1 · kind: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

F1 · price: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000037 · primary_doc.xml · derivative · entry 3

Ribeill Yves J · CIK 0001604049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,291 shares

Expires 2031-05-27

F1 · kind: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

F1 · price: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000037 · primary_doc.xml · derivative · entry 2

Ribeill Yves J · CIK 0001604049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2030-08-04

F1 · kind: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

F1 · price: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000037 · primary_doc.xml · derivative · entry 1

Ribeill Yves J · CIK 0001604049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2030-08-04

F1 · kind: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

F1 · price: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: Teh reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split of its common stock on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000036 · primary_doc.xml · derivative · entry 6

NEUGENT CHRISTOPHER J · CIK 0001657549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,400

Underlying: Common Stock · 36,400 shares

Expires 2032-06-13

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000036 · primary_doc.xml · derivative · entry 5

NEUGENT CHRISTOPHER J · CIK 0001657549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 36,400 shares

Expires 2032-06-13

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000036 · primary_doc.xml · derivative · entry 4

NEUGENT CHRISTOPHER J · CIK 0001657549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,408

Underlying: Common Stock · 14,408 shares

Expires 2031-05-27

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000036 · primary_doc.xml · derivative · entry 3

NEUGENT CHRISTOPHER J · CIK 0001657549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,408 shares

Expires 2031-05-27

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000036 · primary_doc.xml · derivative · entry 2

NEUGENT CHRISTOPHER J · CIK 0001657549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-08-04

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000036 · primary_doc.xml · derivative · entry 1

NEUGENT CHRISTOPHER J · CIK 0001657549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2030-08-04

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000041 · primary_doc.xml · derivative · entry 6

Dumont Philippe · CIK 0001712186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,700

Underlying: Common Stock · 32,700 shares

Expires 2032-06-13

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000041 · primary_doc.xml · derivative · entry 5

Dumont Philippe · CIK 0001712186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 32,700 shares

Expires 2032-06-13

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

SEC source: 0001615594-23-000041 · primary_doc.xml · derivative · entry 4

Dumont Philippe · CIK 0001712186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,291

Underlying: Common Stock · 10,291 shares

Expires 2031-05-27

F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.